Nascent Biotech, Inc.
NBIO · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $47 | $372 | $624 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $182 | $227 | $552 | $641 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$0 |
| Total NC Assets | $0 | $0 | $0 | -$0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $182 | $227 | $552 | $641 |
| Liabilities | – | – | – | – |
| Payables | $804 | $683 | $686 | $484 |
| Short-Term Debt | $59 | $59 | $123 | $125 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $83 | $0 | $0 | $0 |
| Total Curr. Liab. | $946 | $742 | $809 | $611 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $946 | $742 | $809 | $611 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $172 | $172 | $171 | $169 |
| Retained Earnings | -$24,890 | -$24,638 | -$24,260 | -$23,748 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $2 | $0 | $0 | $0 |
| Total Equity | -$764 | -$515 | -$257 | $30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $182 | $227 | $552 | $641 |
| Net Debt | $57 | $12 | -$250 | -$499 |